EDEM3


Summary: Quality control in the endoplasmic reticulum (ER) ensures that only properly folded proteins are retained in the cell through recognition and degradation of misfolded or unassembled proteins. EDEM3 belongs to a group of proteins that accelerate degradation of misfolded glycoproteins in the ER (Hirao et al., 2006 [PubMed 16431915]).[supplied by OMIM, Mar 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in EDEM3


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP IEA GO:0006486 protein glycosylation
BP IMP GO:1904382 mannose trimming involved in glycoprotein ERAD pathway
BP TAS GO:1904382 mannose trimming involved in glycoprotein ERAD pathway
CC IEA GO:0005788 endoplasmic reticulum lumen
CC IEA GO:0016020 membrane
CC TAS GO:0044322 endoplasmic reticulum quality control compartment
Showing 1 to 6 of 9 rows

Gene expression in normal tissue: EDEM3

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in EDEM3


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa04141 Protein processing in endoplasmic reticulum - Homo sapiens (human)
reactome R-HSA-392499 Metabolism of proteins
reactome R-HSA-446203 Asparagine N-linked glycosylation
reactome R-HSA-532668 N-glycan trimming in the ER and Calnexin/Calreticulin cycle
reactome R-HSA-597592 Post-translational protein modification
reactome R-HSA-901032 ER Quality Control Compartment (ERQC)
Showing 1 to 6 of 7 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD409 Saracatinib 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in EDEM3

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​